id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2014-E-1640-0005,FDA,FDA-2014-E-1640,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2022-12-30T05:00:00Z,2022,12,2022-12-30T05:00:00Z,,2022-12-30T13:52:12Z,,0,0,0900006485567135
FDA-2014-E-1640-0004,FDA,FDA-2014-E-1640,Letter from the U.S. Patent and Trademark Office to FDA,Other,Letter(s),2015-09-09T04:00:00Z,2015,9,2015-09-09T04:00:00Z,,2015-09-09T18:24:59Z,,0,0,0900006481c633ba
FDA-2014-E-1640-0003,FDA,FDA-2014-E-1640,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-03-23T04:00:00Z,2015,3,2015-03-23T04:00:00Z,,2015-03-23T14:59:15Z,,0,0,0900006481a59096
FDA-2014-E-1640-0001,FDA,FDA-2014-E-1640,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2014-10-16T04:00:00Z,2014,10,2014-10-16T04:00:00Z,,2014-10-16T21:04:04Z,,0,0,09000064818cb286
FDA-2014-E-1640-0002,FDA,FDA-2014-E-1640,"Patent Extension Application from Finnegan, Henderson, Farabow, Garrett and Dunner, LLP (on behalf of BTG International Limited",Other,Application,2014-10-16T04:00:00Z,2014,10,2014-10-16T04:00:00Z,,2014-10-16T21:04:10Z,,0,0,09000064818cb288